Return to homepagePandemic Pact

FASTER - National Covid-19 vaccine research platform

Grant number: 2021-04809

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $2,985,287.2

  • Funder

    TUBITAK

  • Principal Investigator

    Pontus Naucler

  • Research Location

    Sweden

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    14

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    N/A

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

5 Publications linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

The effect of remdesivir and nirmatrelvir/ritonavir on mortality in patients hospitalized with COVID-19 during the Omicron era: an emulated target trial.

The Effect of COVID-19 Vaccination on the Risk of Persistent Post-COVID-19 Condition: Cohort Study.

Determinants of post COVID-19 clinic attendance among SARS-CoV-2-infected individuals in Stockholm, Sweden: a population-based cohort study.

Post-COVID-19 Condition After SARS-CoV-2 Infections During the Omicron Surge vs the Delta, Alpha, and Wild Type Periods in Stockholm, Sweden.

Clinical outcomes during and beyond different COVID-19 critical illness variant periods compared with other lower respiratory tract infections.